nach oben

Neurocritical Care

Erschienen in:

01.10.2008 | Debates and Arguments

Safety Issues and Concerns for the Neurological Patient in the Emergency Department

verfasst von: Edward M. Manno

Erschienen in: Neurocritical Care | Ausgabe 2/2008

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Patient safety in our medical system has been an increasing national concern. Neurological patient safety in the emergency department (ED) has not been studied. The purpose of this article is thus to describe the issues relevant to neurological patient safety in the ED, review the current status of the literature, identify specific patient populations at risk, and suggest applicable solutions.

Methods

Medline and PubMed literature review of key words associated with patient safety, neurological diseases, and EDs.

Results

Little data can be found on overall neurological patient safety in the ED, however data for specific neurological emergencies including subarachnoid hemorrhage, stroke, status epilepticus, and head and spine trauma does exist and is reviewed.

Conclusions

Limitations in ED education and access to neurological expertise may place some patients at risk. Recommendations for improving neurological patient safety in the EDs are suggested and include a discussion on barriers to implementation.

Institute of Medicine. To Err is Human: building a safer health system. http://www.nap.edu/books/0309068371/html/; 2000 National Academy of Sciences. Accessed May 2007.

Ferro JM, Pinto AN, Falcao I, Rodrigues G, Ferreira J, Falcao F et al. Diagnosis of stroke by the nonneurologist: a validation study. Stroke. 1998;29:1106–9.PubMed

Glick TH. The neurologist and patient safety. The Neurologist. 2005;11:140–9.PubMedCrossRef

Kothari RU, Brott T, Broderick JP, Hamilton CA. Emergency physicians: accuracy in the diagnosis of stroke. Stroke. 1995;26:2238–41.PubMed

Harbison J, Hossain O, Jenkinson D, Davis J, Louw SJ, Ford GA. Diagnostic accuracy of stroke referrals from primary care, emergency room physicians, and ambulance staff using the face, arm, speech test. Stroke. 2003;34:71–6.PubMedCrossRef

Morgenstern LB, Lisabeth LD, Mecozzi BA, Smith MA, Longwell PJ, McFarling DA et al. A population based study of acute stroke and TIA diagnosis. Neurology. 2004;62:895–900.PubMed

Libman RB, Wirkowski E, Alvir J, Hemanth RT. Conditions that mimic stroke in the emergency department: implications for an acute stroke trial. Arch Neurol. 1995;52:1119–22.PubMed

Tissue Plasminogen Activator for Acute Stroke. The National Institute of Neurological Disorders and Stroke ft-PA Stroke study group. N Engl J Med. 1995;333:1581–7.CrossRef

Katzan IL, Furlan AJ, Lloyd LE, Frank JI, Harper DL, Hinchey JA et al. Use of tissue-type plasminogen activator fro acute ischemic stroke: the Cleveland area experience. JAMA. 2000;9:1151–8.CrossRef

10.

Ruland S, Gorelick PB, Schneck M, Kim D, Moore CG, Leurgans S. Acute stroke care in Illinois: a statewide assessment of diagnostic and treatment capabilities. Stroke. 2002;33:1334–9.PubMedCrossRef

11.

Hoffman J. IV t-PA interventional therapy for acute stroke patients: negative position. Stroke Intervent. 2002;11:6–10.

12.

Schumacher HC, Bateman BT, Boden-Albala B, Berman MF, Mohr JP, Sacco Rl et al. Use of thrombolysis in acute ischemic stroke: analysis of the Nationwide Inpatient sample 1999 to 2004. Ann Emerg Med. 2007;50:99–107.PubMedCrossRef

13.

Adams JG, Chisolm CD. The society of academic emergency medicine position on optimizing care of the stroke patient. Acad Emerg Med. 2003;10:805.PubMedCrossRef

14.

Jauch E. Society for Academic Emergency Medicine (SAEM) neurologic emergencies interest group response to the SAEM board position on optimizing care of the stroke patient. Acad Emer Med. 2004;11:116–8.

15.

Bratina P, Greenberg L, Pasteur W, Grotta JC. Current emergency department management of stroke in Houston Texas. Stroke. 1995;26:409–14.PubMed

16.

Lopez-Yunez AM, Bruno A, Williams LS, Yilmaz E, Zurrie C, Biller J. Protocol violations in community based rt-PA stroke treatment are associated with symptomatic intracerebral hemorrhage. Stroke. 2001;32:12–6.PubMed

17.

Scott PA, Silbergleit R. Misdiagnosis of stroke in tissue plasminogen activator treated patients: characteristics and outcomes. Ann Emerg Med. 2003;42:611–8.PubMedCrossRef

18.

Renata DG, Novaes HMD, Lorenzi MC, Eluf-Neto J, Okamura MN, Valesco IT. Adverse events and death in stroke patients admitted to the emergency department of a tertiary university hospital. Euro J Emerg. Med. 2005;12:63–71.CrossRef

19.

Brott T, Broderick J, Kothari R, Barsan W, Tomsick T, Sauerbeck L et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke. 1997;28:1–5.PubMed

20.

Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN et al. Recombinant activated factor VII intracerebral hemorrhage trial investigators. Recombinant factor VII for acute intracerebral hemorrhage. N Engl J Med. 2005;352:777–85.PubMedCrossRef

21.

Mayer SA, Brun NC, Broderick J, Davis SM, Diringer MN, Skolnick BE et al. United States NovoSeven ICH trial investigators. Recombinant activated factor VII for acute intracerebral hemorrhage: US phase IIA trial. Neurocrit Care. 2006;4:206–314.PubMedCrossRef

22.

Mayer SA, Brun NC, Begtrup K, Davis S, Diringer MN et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. New Engl J Med. 2008;358:2127–37.

23.

Broderick J, Connolly S, Feldmann E, Hanley D, Kase C, Krieger D et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update. Stroke. 2007;38:2001–23.PubMedCrossRef

24.

Powers WJ, Zazulia AR, Videen TO, Adams RE, Yundt KD, Aiyagari V et al. Autoregulation of cerebral blood flow surrounding acute (6–22 hours) intracerebral hemorrhage. Neurology. 2001;57:18–24.PubMedCrossRef

25.

Kassell NF, Konable GL, Torner JC, Adams HP Jr, Mazuz H. Delay in referral of patients with ruptured aneurysms to neurosurgical attention. Stroke. 1985;16:587–90.PubMed

26.

Mayer PL, Awad IA, Todor R, Harbaugh K, Varnavas G, Lansen TA et al. Misdiagnosis of symptomatic cerebral aneurysms: prevalence and correlation with outcome at four institutions. Stroke. 1996;27:1558–63.PubMed

27.

Edlow JA, Caplan LR. Avoiding pitfalls in the diagnosis of subarachnoid hemorrhage. New Engl J Med. 2000;342:29–36.PubMedCrossRef

28.

Kowalski RG, Claasen J, Kreiter KT, Bates JE, Ostapkovich ND, Connolly ES, Mayer SA. Initial misdiagnosis and outcome after subarachnoid hemorrhage. JAMA. 2004;18:866–9.CrossRef

29.

Vermeulan MJ, Schull MJ. Missed diagnosis of subarachnoid hemorrhage in the emergency department. Stroke. 2007;38:1216–21.CrossRef

30.

Edlow JA. Diagnosis of subarachnoid hemorrhage: are we doing better? Stroke. 2007;38:1129–31.

31.

Manno EM. New management strategies in the treatment of status epilepticus. Mayo Clin Proc. 2003;78:508–18.PubMed

32.

Treatment of convulsive status epilepticus: recommendations of the Epilepsy Foundation of Americas working group on Status Epilepticus. JAMA. 1993;270:854–9.

33.

Lowenstein DH. Status epilepticus: an overview of the clinical problem. Epilepsia. 1999;40(Suppl 1):S3–S8.PubMedCrossRef

34.

Theodore WH, Porter RJ, Alpert P, Kelley K, Bromfield E, Devinsky O et al. The secondary generalized tonic-clonic seizure: a videotape analysis. Neurology. 1994;44:1403–7.PubMed

35.

Treiman DM. Status epilepticus. Baillieres Clin Ceurol. 1996;5:821–39.

36.

Walker MC, Cockerell OC, Sander JWAS. Non-convulsive status epilepticus presenting as a psychiatric condition. J R Soc Med. 1996;89:91–2.PubMed

37.

Holtkamp M, Othman J, Buchheim K, Meierkord H. Diagnosis of psychogenic nonepileptic status epilepticus in the emergency setting. Neurology. 2006;66:1727–9.PubMedCrossRef

38.

Whitaker JN. The confluence of quality of care, cost-effectiveness, pragmatism, and medical ethics in the diagnosis of nonepileptic seizures: a provocative situation in neurology. Arch Neurol. 2001;58:2066–7.PubMedCrossRef

39.

Dworetzky BA, Bromfield EB. Differential diagnosis of status epilepticus: Pseudostatus epilepticus, Chapter 3. In: Drislane FW, editor. Status Epilepticus: a clinical perspective. New Jersey: Humana Press Towata; 2005. p. 33–54.

40.

Alldredge BK, Gelb AM, Issacs SM et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out of hospital status epilepticus. NEJM. 2001;345:631–7.PubMedCrossRef

41.

Bulger EM, Nathens AB, Rivara FP, Moore M, Mac Kenzie EJ, Jurkovich GJ. Management of severe head injury: institutional variations in care and effect on outcome. Crit Care Med. 2002;30:1870–76.

42.

Vellman P, Hawkws AP, Lammertse DP. Administration of corticosteroids for acute spinal cord injury: the current practice of trauma medical directors and emergency medical system physician advisors. Spine. 2003;28:941–947.CrossRef

43.

Muolin T, Berger E, Lemounaud P, Vuillier F, Tatu L, Sablot D et al. Consultation de neurolgie en urgence dans un centre hospitalier universitaire: apport du neurologue dans la prose en charge du patient. Rev Neurol (Paris). 2000;156:727–35.

44.

Bray JE, Martin J, Cooper G, Barger B, Bernard S, Blandin C. An interventional study to improve paramedic diagnosis of stroke. Prehospital Emerg Care. 2005;9:297–392.CrossRef

45.

Katzan IL, Hammer MD, Furlan AJ, Hixson ED, Nadzam DM. Quality improvement and tissue-type plasminogen activator for acute ischemic stroke. A Cleveland update. Stroke. 2003;34:799–800.PubMedCrossRef

46.

Morgenstern LB, Bartholomew K, Grotta JC, Straub L, King M, Chan W. Sustained benefit of a community and professional intervention to increase stroke therapy. Arch Intern Med. 2003;163:2198–202.PubMedCrossRef

47.

Wibborg A, Widder B, for the TESS Study group. Teleneurology to improve stroke care in rural areas. The telemedicine in stroke in Swabia (TESS) project. Stroke. 2003;34:2951–7.CrossRef

48.

Wang DZ. Telemedicine: the solution to provide rural stroke coverage and the answer to the shortage of stroke neurologists and radiologists. Stroke. 2003;34:2957.PubMedCrossRef

49.

Burstin HR, Conn A, Setnik G, Rucker DW, Cleary PD, O'Nell AC et al. Benchmarking and quality improvement: the Harvard emergency department quality study. Am J Med. 1999;107:437–49.PubMedCrossRef

50.

Physicians Insurers Association of America (PIAA). Neurology Claims (300 Paid Claims Study). Rockville, MD: PIAA; 2004.

51.

Stettler BA, Jauch EC, Kissela B, Lindsell CJ. Neurologic education in emergency medicine training programs. Acad Emerg Med. 2005;12:909–11.PubMedCrossRef

Titel: Safety Issues and Concerns for the Neurological Patient in the Emergency Department
verfasst von: Edward M. Manno
Publikationsdatum: 01.10.2008
Verlag: Humana Press Inc
Erschienen in: Neurocritical Care / Ausgabe 2/2008
Print ISSN: 1541-6933
Elektronische ISSN: 1556-0961
DOI: https://doi.org/10.1007/s12028-008-9111-x

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Schwindelursache: Massagepistole lässt Otholiten tanzen

14.05.2024 Benigner Lagerungsschwindel Nachrichten

Wenn jüngere Menschen über ständig rezidivierenden Lagerungsschwindel klagen, könnte eine Massagepistole der Auslöser sein. In JAMA Otolaryngology warnt ein Team vor der Anwendung hochpotenter Geräte im Bereich des Nackens.

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Viertel reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Introduction

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2008

Hyperglycemia and Short-term Outcome in Patients with Spontaneous Intracerebral Hemorrhage

Packed Red Blood Cell Transfusion Causes Greater Hemoglobin Rise at a Lower Starting Hemoglobin in Patients with Subarachnoid Hemorrhage

Variation in Osmotic Response to Sustained Mannitol Administration

Intensive Insulin Therapy After Severe Traumatic Brain Injury: A Randomized Clinical Trial

Eligibility for the Surgical Trial in Intracerebral Hemorrhage II Study in a Population-based Cohort